Evidence map›Paper›PMID 24653624›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2014

Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy.

Kimiteru Ito, Keigo Shimoji, Yoko Miyata, Kouhei Kamiya, Ryogo Minamimoto, Kazuo Kubota, Momoko Okasaki, Miyako Morooka, Jyunkichi Yokoyama

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2016
    Review
  4. Article
  5. Impact and prognostic value ofSouth Asian journal of cancer
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kimiteru Ito1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Keigo Shimoji1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Yoko Miyata1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Kouhei Kamiya1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Ryogo Minamimoto1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Kazuo Kubota1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Momoko Okasaki1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Miyako Morooka1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Jyunkichi Yokoyama1 Department of Radiology, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan ; 2 Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan ; 3 Division of nuclear Medicine, International Medical Center of Global Health, Tokyo 162-8655, Japan ; 4 Department of Otolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Juntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo clarify the prognostic value of post-treatment (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in patients with advanced head and neck squamous cell carcinoma (HNSCC) after combined intra-arterial chemotherapy and radiotherapy (IACR).

methodsThirty-six patients with HNSCC who underwent IACR were recruited. The period from the end of IACR to the last post-treatment (18)F-FDG PET/CT examination was 8-12 weeks. Both patient-based and lesion-based analyses were used to evaluate the PET/CT images. For lesion-based analysis, 36 regions (12 lesions of recurrences and 24 scars at primary sites) were selected. The Kaplan-Meier method was used to assess the overall survival (OS) stratified by (18)F-FDG uptake or visual interpretation results.

resultsTwelve patients with recurrence were identified by six months after IACR. The sensitivity and specificity in the patient-based analysis were 67% (8/12) and 88% (21/24), respectively. The mean OS was estimated to be 12.1 months (95% CI, 6.3-18.0 months) for the higher maximum standardized uptake value (SUVmax) group (n=7) and 44.6 months (95% CI, 39.9-49.3 months) for the lower SUVmax group (n=29). OS in the higher SUVmax group (cut-off point, 6.1) or positive visual interpretation group was significantly shorter than that in the lower SUVmax or negative visual interpretation group (P<0.001 and P<0.05, respectively).

conclusionsThe SUVmax and visual interpretation of HNSCC on post-IACR (18)F-FDG PET/CT can provide prognostic survival estimates.

Indexed as

18F-fluorodeoxyglucose (18F-FDG)head and neck cancerintra-arterial chemotherapy and radiotherapy (IACR)positron emission tomography (PET)/computed tomography (CT)recurrencesurvival time

Identifiers

PMID24653624
PMCPMC3937750
OpenAlexW1743091817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.